The U.S. Food and Drug Administration (FDA) approved Belgian drugmaker UCB SA’s drug as an add-on therapy to treat partial seizures caused by epilepsy. The FDA approval comes nearly two months after the European health regulators recommended …
The U.S. Food and Drug Administration (FDA) approved Belgian drugmaker UCB SA’s drug as an add-on therapy to treat partial seizures caused by epilepsy. The FDA approval comes nearly two months after the European health regulators recommended …
By clicking “SUBSCRIBE NOW,” you agree to receive emails from Ability Today and accept our web terms of use and privacy and cookie policy.
